NDC 27854-555

Belmora Flanax

Naproxen Sodium

Belmora Flanax is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Belmora Llc. The primary component is Naproxen Sodium.

Product ID27854-555_75a20e0f-cf1e-4de8-892f-82bf9ab926e8
NDC27854-555
Product TypeHuman Otc Drug
Proprietary NameBelmora Flanax
Generic NameNaproxen Sodium
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-07-20
Marketing CategoryANDA / ANDA
Application NumberANDA090545
Labeler NameBelmora LLC
Substance NameNAPROXEN SODIUM
Active Ingredient Strength220 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 27854-555-01

1 BOTTLE in 1 CARTON (27854-555-01) > 24 TABLET in 1 BOTTLE
Marketing Start Date2020-09-14
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Belmora Flanax" or generic name "Naproxen Sodium"

NDCBrand NameGeneric Name
27854-555Belmora FlanaxBelmora Flanax
0280-6000AleveNAPROXEN SODIUM
0280-6010AleveNAPROXEN SODIUM
0280-6020AleveNAPROXEN SODIUM
0280-0041Aleve Headache PainNaproxen Sodium
0113-7033basic care naproxen sodiumNaproxen Sodium
0113-7368Basic Care Naproxen SodiumNaproxen Sodium
0113-7901basic care naproxen sodiumNaproxen Sodium
0113-0901Good Sense Naproxen SodiumNaproxen Sodium
0113-1412good sense naproxen sodiumnaproxen sodium
0113-1773good sense naproxen sodiumNaproxen Sodium
0113-4368Good Sense Naproxen SodiumNaproxen Sodium
0280-0270MenstridolNAPROXEN SODIUM
0143-9908NAPROXENnaproxen sodium
0143-9916NAPROXENnaproxen sodium

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.